There has been a significant increase in chronic diseases in the United States and the increase is more specifically related to autoimmune disorders. These chronic diseases and ailments can be attributed to various environmental problems termed “stealthy pathogens” or “cell wall deficient forms” resulting from a plethora of vaccine-related chronic diseases and human parasitic infestations.
Autoimmune conditions are infections that affect the immune system, stealthy pathogens and intracellular parasites are known to create autoimmune responses such as; Chronic Fatigue Syndrome. Fibromyalgia is also closely related to chronic fatigue syndrome. Although these conditions are rare, a clinical report has indicated that stress, enzyme deficiencies, and physical and/or emotional trauma accelerate autoimmune disorders that play a vital and serious role in the onset of Chronic Fatigue Syndrome.
The near epidemic rise in some of these indications and disorders in recent years has been labeled the lifestyle disease. Alternatively, it can be described as diseases that can be caught from others as they are infectious while some are inactive at certain times. However, they are on the rise due to various environmental factors such as radiation, diet, trauma, stress, intestinal parasites, and the like.
Immuzyme® is formulated and developed by Life Sources® Inc. This incredible enzyme-driven formula helps relieve the complications, symptoms, and causes of various autoimmune disorders such as Chronic Fatigue Syndrome, Rheumatoid Arthritis, Fibromyalgia, Multiple Sclerosis and many other health problems related to immune dysfunction. causing inflammation of tissues and muscles.
Aluminum toxicity is strongly and highly suspected to be more dangerous than originally believed. Magnesium and malate are the two key nutrients that absorb and process oxygen efficiently. Similarly, the body is unable to process the required oxygenation due to a magnesium deficiency. Additionally, magnesium deficiency is directly associated with aluminum toxicity identified in the blood and other common autoimmune disorders. Additionally, magnesium deficiency decreases the body’s ability to block the toxic effects of aluminum. The reluctance of the human energy cycle that depends on the magnesium content, ie the Krebs cycle is the main cause of several chronic diseases along with fibrinogen found in heart patients and fibromyalgia patients alike.
The malic acid in Immuzyme® significantly increases urinary aluminum secretion from the body and reduces the aluminum concentration of internal organs. It is a superior chelate and acts as an extraordinary detoxifier of the aluminum content in the body.
Manganese is most important in neuroendocrine changes for regulation of metabolism by thyroxine release in conjunction with hypothalamic pituitary thyroid. Immuzyme® helps prevent manganese deficiency.
Thus, the Immuzyme formulation has been shown to relieve conditions considered chronic disorders, where chronic inflammation causes anything from mild to extreme pain, hypertension, chronic fatigue, fibromyalgia, multiple sclerosis, restless leg symptoms, rheumatoid arthritis, soft tissue rheumatisms, irritable bowel syndrome, bacterial infections, cardiovascular diseases, bladder infections, muscle tension headaches, poor wound healing, stressed adrenal glands, infertility, stroke, peripheral vascular disease, varicose veins and many more that have been implicated.